Managing Director, Westlake Village BioPartners
David Allison is a Managing Director at Westlake BioPartners and is based in the San Francisco Bay Area. Dr. Allison has spent the past 15 years in biotechnology venture capital, including most recently as a partner at 5AM Ventures. While at 5AM, he was involved in investments including CinCor Pharma (acquired by AstraZeneca), Crinetics Pharmaceuticals, Impel Neuropharma, Inipharm, Neurogastrx, and Radionetics. Prior to 5AM, Dr. Allison was a principal at Versant Ventures and held previous roles at Split Rock Partners and PTV Healthcare Capital. He received a Ph.D. from Rice University and a B.S.E. from The University of Iowa.